Showing 991-1000 of 1782 results for "".
- Transformative AI: Unlocking the Future of Point-of-Care Ultrasoundhttps://reachmd.com/news/transformative-ai-unlocking-the-future-of-point-of-care-ultrasound/2485451/Qure.ai has received a multimillion-dollar grant from the Gates Foundation to support the development of a large, o
- Nirsevimab: A Turning Point in RSV Prophylaxis for Infantshttps://reachmd.com/news/nirsevimab-a-turning-point-in-rsv-prophylaxis-for-infants/2475966/Respiratory syncytial virus continues to drive significant morbidity in infants, yet prevention efforts have lagged behind advances in treatment, leaving a critical window of vulnerability in the youngest patients. For pediatric infectious disease specialists, the advent of long-acti
- FDA Approval of Suzetrigine: A Turning Point in Pain Managementhttps://reachmd.com/news/fda-approval-of-suzetrigine-a-turning-point-in-pain-management/2475424/In a landscape strained by the fallout of opioid overuse, the FDA approval of suzetrigine marks a sig
- Scientists Find Weak Points on Epstein-Barr Virushttps://reachmd.com/news/scientists-find-weak-points-on-epstein-barr-virus/2462294/An electron micrograph showing three EBV virions in red-orange. Credit: NIAID Studies of interactions between two lab
- New Study Points to Supply Chain Disruptionshttps://reachmd.com/news/new-study-points-to-supply-chain-disruptions/2457110/2/8/2024 PITTSBURGH — In a new study of nasal decongestant purchasing patterns, researchers at the University of Pittsburgh School of Medicine found that phenylephrine remained the most popular choice year after year, despite decades of conce
- Advancing Precision Diagnostics at Patient's Point-of-Carehttps://reachmd.com/news/advancing-precision-diagnostics-at-patients-point-of-care/2457119/Novel micrometer-thick porous coating with unparalleled biomarker detection abilities broadens diagnostic horizon for multiplexed electrochemical sensors across multiple diseases.By Benjamin Boettner(Boston) — Aging populations and the tendency to lead a more sedentar
- AVAVA Receives FDA Clearance for Acne Scar Treatment on All Skin Types Using Focal Point Technologyhttps://reachmd.com/news/avava-receives-fda-clearance-for-acne-scar-treatment-on-all-skin-types-using-focal-point-technology/2474516/The U.S. Food and Drug Administration (FDA) has cleared AVAVA’s Focal Point Technology™ for the treatment of acne scars, marking a significant milestone in energy-based skin therapy. The technology, developed by Boston-based AVAVA, is now indicated for acne scarring in all Fitzpatrick skin types
- AVAVA Receives FDA Clearance for Acne Scar Treatment on All Skin Types Using Focal Point Technologyhttps://reachmd.com/news/avava-receives-fda-clearance-for-acne-scar-treatment-on-all-skin-types-using-focal-point-technology/2474319/The U.S. Food and Drug Administration (FDA) has cleared AVAVA’s Focal Point Technology™ for the treatment of acne scars, marking a significant milestone in energy-based skin therapy. The technology, developed by Boston-based AVAVA, is now indicated for acne scarring in all Fitzpatrick sk
- AVAVA Receives FDA Clearance for Acne Scar Treatment on All Skin Types Using Focal Point Technologyhttps://reachmd.com/news/avava-receives-fda-clearance-for-acne-scar-treatment-on-all-skin-types-using-focal-point-technology/2475350/The U.S. Food and Drug Administration (FDA) has cleared AVAVA’s Focal Point Technology™ for the treatment of acne scars, marking a significant milestone in energy-based skin therapy. The technology, developed by Boston-based AVAVA, is now indicated for acne scarring in all Fitzpatrick skin types
- Study Finds Potential New Treatment Path for Lasting Lyme Disease Symptomshttps://reachmd.com/news/study-finds-potential-new-treatment-path-for-lasting-lyme-disease-symptoms/2462797/Expression levels of FGFRs from rhesus frontal cortex (FC) in response to live and non-viable B burgdorferi. FC tissue explants exposed to either live or sonicated B burg